Multi-Drug 10 in 1 Urine Test Panel
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- rapid test, urine, multi drug
- Category
- Medical Devices
Hangzhou Laihe Biotech Co., Ltd.
China
- Verified Certificate
-
7
| Product name | Multi-Drug 10 in 1 Urine Test Panel | Certification | - |
|---|---|---|---|
| Category | Medical Devices | Ingredients | - |
| Keyword | rapid test , urine , multi drug | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
1. Product Details
Test Name: The Multi-Drug 10 in 1 Urine Test Panel
Format: Panel
Test Item:
Any combination of customized drugs
AMP/BZO/BAR/BUP/COC/THC/MTD/MET/Ecstacy/MOP/OPI/OXY/PCP/PPX/TCA
Specimen: Urine
Storage: 2-30°C
2. Principle
Drugs which may be present in the urine specimen compete against their respective drug conjugate for binding sites on their specific antibody.
During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody coated on the particles. The antibody coated particles will then be captured by the immobilized drug conjugate and a visible colored line will show up in the test line region of the specific drug strip. The colored line will not form in the test line region if the drug level is above its cut-off concentration because it will saturate all the binding sites of the antibody coated on the particles.
A drug-positive urine specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration less than the cut-off will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
Hangzhou Laihe Biotech Co., Ltd
Contact: Helen
Tel: +86-571-86658003
Fax: +86-571-86658000
Zip:310052
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ouyangyun
- Address
- Room 521 Floor 5 & Floor 1,Building No. 2B,Tianhe High-Tech Park,No. 688,Bin'an Road,Changhe Sub-district,Binjiang District,Hangzhou City,Zhejiang Province,China
- Product Category
- Pharmaceuticals
- Year Established
- 2012
- No. of Total Employees
- 51-100
- Company introduction
-
Hangzhou Laihe Biotech Co., Ltd. (hereafter referred to as “Laihe Biotech”) is a life science company specialized in R & D, manufacturing, marketing and service in point-of-care testing, monitoring and health technology industry, is committed to provide fast, accurate and reliable health detection products and services. Founded by Dr returned from United States in February 2012, today Laihe Biotech have a team of experienced scientists researching and developing diagnostic products, and have already built an independent POCT platform which including various rapid test products like Cardiac Marker Series (cTnI, NT-proBNP, H-FABP, etc.), Inflammation Series (hs-CRP, PCT, etc.), Tumor Marker Series (AFP, CEA, etc.), Diabetes Monitoring Series (HbA1c), Fertility Series (TORCH) and Infectious Diseases Series.
- Main Markets
-
Argentina
Brazil
Germany
India
Indonesia
Iran
Israel
Mexico
Niger
U.S.A
- Main Product
